Cyclophosphamide induction regimens. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cells, Cultured Spleen Cell Line Bone Marrow Antilymphocyte Serum T-Lymphocytes Cell Line, Tumor Tumor Cells, Cultured Liver T-Lymphocytes, Regulatory Lymph Nodes B-Lymphocytes Lung Bone Marrow Cells Lymphocytes

Organisms9

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Inbred Strains Mice, Inbred C3H Rats, Sprague-Dawley Mice, Knockout Mice, Inbred DBA Transplantation Chimera Mice, Inbred ICR

Diseases55

Multiple Myeloma Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myeloid, Acute Breast Neoplasms Acute Disease Lymphoma, Non-Hodgkin Leukopenia Cystitis Recurrence Neutropenia Lupus Nephritis Wegener Granulomatosis Graft vs Host Disease Lymphoma, Large B-Cell, Diffuse Vomiting Anemia, Aplastic Thrombocytopenia Leukemia, Lymphocytic, Chronic, B-Cell Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Lung Neoplasms Nausea Lymphoma Neoplasms Neoplasm Metastasis Hodgkin Disease Carcinoma, Small Cell Disease Models, Animal Hematologic Diseases Hypersensitivity, Delayed Lymphoma, Follicular Microscopic Polyangiitis Neoplasms, Experimental Neoplasm Recurrence, Local Disease Progression Leukemia Ovarian Neoplasms Vasculitis Nephrotic Syndrome Lymphatic Metastasis Alopecia Sarcoma, Experimental Lymphoma, B-Cell Polyarteritis Nodosa Amenorrhea Infection Leukemia L1210 Lung Diseases, Interstitial Hematologic Neoplasms Rhabdomyosarcoma Lupus Erythematosus, Systemic Leukemia, Myeloid Primary Ovarian Insufficiency Mammary Neoplasms, Experimental Churg-Strauss Syndrome Lymphoma, Mantle-Cell

Chemicals and Drugs87

Cyclophosphamide Vincristine Cytarabine Doxorubicin Prednisone Etoposide Daunorubicin Boronic Acids Pyrazines Phosphoramide Mustards Asparaginase Antineoplastic Agents, Alkylating Dexamethasone Cisplatin Antineoplastic Agents Immunosuppressive Agents Methotrexate Epirubicin Busulfan Fluorouracil Thiotepa Prednisolone Antibodies, Monoclonal, Murine-Derived Vidarabine Granulocyte Colony-Stimulating Factor Methylprednisolone Melphalan Carmustine Ifosfamide Bleomycin Azathioprine Mitoxantrone Mesna Paclitaxel Antibodies, Monoclonal RNA, Messenger Chlorambucil Procarbazine Carboplatin Alkylating Agents Acrolein Taxoids Antilymphocyte Serum Recombinant Proteins Vinblastine Myeloablative Agonists Mycophenolic Acid Mechlorethamine Glucocorticoids Anthracyclines Antibiotics, Antineoplastic Dactinomycin Cyclosporine Cytochrome P-450 CYP2B1 Amifostine Antineoplastic Agents, Phytogenic Mutagens Lomustine DNA-Binding Proteins Transcription Factors Prodrugs Antibodies, Monoclonal, Humanized Ondansetron Antibodies, Antineutrophil Cytoplasmic Vindesine Drug Combinations Thalidomide Granulocyte-Macrophage Colony-Stimulating Factor Leucovorin Antiemetics Oxidoreductases, N-Demethylating Deoxycytidine Aryl Hydrocarbon Hydroxylases Dacarbazine Cytochrome P-450 Enzyme System Teniposide Cladribine Interferon-gamma Misonidazole Adjuvants, Immunologic Anti-Inflammatory Agents Mitomycins Topotecan Adrenal Cortex Hormones Pentostatin Cytokines Organothiophosphorus Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment61

Induction Chemotherapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Drug Administration Schedule Treatment Outcome Transplantation, Autologous Combined Modality Therapy Disease-Free Survival Drug Therapy, Combination Hematopoietic Stem Cell Transplantation Survival Analysis Survival Rate Stem Cell Transplantation Prognosis Pulse Therapy, Drug Prospective Studies Bone Marrow Transplantation Whole-Body Irradiation Transplantation Conditioning Chemotherapy, Adjuvant Immunosuppression Administration, Metronomic Follow-Up Studies Transplantation, Homologous Infusions, Intravenous Administration, Oral Hematopoietic Stem Cell Mobilization Neoplasm Staging Leukocyte Count Retrospective Studies Salvage Therapy Injections, Intravenous Clinical Trials as Topic Drug Evaluation Neoadjuvant Therapy Random Allocation Neoplasm Transplantation Disease Models, Animal Pilot Projects Neoplasms, Experimental Actuarial Analysis Leukapheresis Immunotherapy Immunization, Passive Feasibility Studies Treatment Failure Sarcoma, Experimental Peripheral Blood Stem Cell Transplantation Bone Marrow Purging Plasmapheresis Flow Cytometry Blood Cell Count Mastectomy, Radical Kaplan-Meier Estimate Immunohistochemistry Lymphocyte Activation Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Mammary Neoplasms, Experimental Maximum Tolerated Dose Injections, Subcutaneous

Phenomena and Processes32

Enzyme Induction Time Factors Dose-Response Relationship, Drug Leukocyte Count Apoptosis Embryonic Induction Signal Transduction Gene Expression Regulation Drug Synergism Graft Survival Biotransformation Immune Tolerance Cell Survival Antibody Formation Base Sequence Cell Division Drug Resistance Transcription, Genetic Promoter Regions, Genetic Blood Cell Count Kinetics Graft Rejection Gene Expression Cell Differentiation Mutation Lymphocyte Activation Drug Resistance, Neoplasm Up-Regulation Maximum Tolerated Dose Immunity, Cellular Drug Interactions Cell Proliferation

Disciplines and Occupations1

Immunohistochemistry

Information Science3

Survival Rate Molecular Sequence Data Base Sequence

Health Care14

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Prospective Studies Follow-Up Studies Retrospective Studies Clinical Trials as Topic Random Allocation Pilot Projects Actuarial Analysis Feasibility Studies Treatment Failure Kaplan-Meier Estimate

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Cyclophosphamide Induction Chemotherapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Vincristine Cytarabine Doxorubicin Drug Administration Schedule Treatment Outcome Prednisone Transplantation, Autologous Etoposide Combined Modality Therapy Daunorubicin Boronic Acids Pyrazines Multiple Myeloma Disease-Free Survival Phosphoramide Mustards Asparaginase Antineoplastic Agents, Alkylating Dexamethasone Drug Therapy, Combination Hematopoietic Stem Cell Transplantation Enzyme Induction Survival Analysis Cisplatin Time Factors Survival Rate Antineoplastic Agents Immunosuppressive Agents Precursor Cell Lymphoblastic Leukemia-Lymphoma Methotrexate Leukemia, Myeloid, Acute Stem Cell Transplantation Prognosis Epirubicin Pulse Therapy, Drug Busulfan Dose-Response Relationship, Drug Fluorouracil Prospective Studies Thiotepa Breast Neoplasms Prednisolone Acute Disease Antibodies, Monoclonal, Murine-Derived Vidarabine Bone Marrow Transplantation Lymphoma, Non-Hodgkin Granulocyte Colony-Stimulating Factor Leukopenia Whole-Body Irradiation Transplantation Conditioning Chemotherapy, Adjuvant Methylprednisolone Melphalan Carmustine Cystitis Immunosuppression Administration, Metronomic Ifosfamide Recurrence Follow-Up Studies Neutropenia Bleomycin Transplantation, Homologous Azathioprine Infusions, Intravenous Mitoxantrone Administration, Oral Mesna Paclitaxel Mice, Inbred C57BL Lupus Nephritis Wegener Granulomatosis Antibodies, Monoclonal RNA, Messenger Chlorambucil Mice, Inbred BALB C Procarbazine Carboplatin Cells, Cultured Alkylating Agents Hematopoietic Stem Cell Mobilization Spleen Neoplasm Staging Leukocyte Count Apoptosis Acrolein Taxoids Retrospective Studies Salvage Therapy Graft vs Host Disease Injections, Intravenous Lymphoma, Large B-Cell, Diffuse Vomiting Clinical Trials as Topic Mice, Inbred Strains Anemia, Aplastic

No FAQ available that match "cyclophosphamide induction regimens"